Get the Stockscreener App
0.00
100.00%
-2.99
Entero Therapeutics Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
See More
Previous Close:
$2.99
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$10.05M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$5.84
Entero Therapeutics Inc Stock (ENTO) Company Profile
Name
Entero Therapeutics Inc
Sector
Industry
Phone
561-589-7020
Address
777 YAMATO ROAD, BOCA RATON
Compare ENTO vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENTO
Entero Therapeutics Inc
|
0.00 | 10.05M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Entero Therapeutics Inc Stock (ENTO) Latest News
GridAI Technologies (NASDAQ: GRDX) Highlights Growth Strategy at Intersection of AI and Power Management - The Globe and Mail
GridAI Technologies (GRDX) Highlights Growth Strategy at Intersection of AI and Power Management - NewMediaWire
Is Entero Therapeutics Inc.’s growth already priced inQuarterly Portfolio Review & AI Forecasted Stock Moves - mfd.ru
Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy - Galesburg Register Mail
Can Entero Therapeutics Inc. stock continue upward trendPortfolio Update Report & Entry Point Confirmation Signals - mfd.ru
Why is Entero Therapeutics Inc. stock going downMarket Performance Recap & Detailed Earnings Play Alerts - mfd.ru
Signal Recap: Why is Entero Therapeutics Inc stock going downTrade Analysis Summary & Accurate Entry/Exit Alerts - baoquankhu1.vn
Analyst Upgrade: Can Entero Therapeutics Inc expand into new marketsJuly 2025 Weekly Recap & Risk Controlled Swing Alerts - baoquankhu1.vn
Tim Healy appointed executive chairman at GridAI Technologies By Investing.com - Investing.com Nigeria
Forecast Cut: Why is Entero Therapeutics Inc stock going upMarket Sentiment Review & Real-Time Volume Spike Alerts - baoquankhu1.vn
Entero Therapeutics, Inc. Announces Corporate Name Change to GridAI Technologies Corp. and New Ticker Symbol "GRDX" - Canton Repository
What are Entero Therapeutics Inc.’s recent SEC filings showingBear Alert & Advanced Swing Trade Entry Alerts - mfd.ru
Update Recap: Is Entero Therapeutics Inc likely to announce a buybackQuarterly Portfolio Summary & Accurate Trade Setup Notifications - baoquankhu1.vn
Earnings Update: Is Entero Therapeutics Inc stock undervalued right nowQuarterly Trade Summary & Daily Growth Stock Investment Tips - baoquankhu1.vn
GridAI Technologies (NASDAQ: GRDX) Engages IBN to Support Corporate Communications Strategy - Digital Journal
GridAI Technologies Partners with IBN to Enhance Corporate Communications - Intellectia AI
IBN Initiates Coverage of GridAI Technologies Corp. - The Manila Times
ENTO Subsidiary Grid AI Announces Letter of Intent with First Hyperscaler AI Data-Center Customer - Corpus Christi Caller-Times
GridAI Technologies (NASDAQ: GRDX) Positions Itself at the Operating Layer of a Continuously Managed Electric Grid - Digital Journal
GridAI Technologies (GRDX) Positions Itself at the Operating Layer of a Continuously Managed Electric Grid - NewMediaWire
Whittier Daily News - FinancialContent
GridAI and the New Operating Reality of the Electric Grid - The Globe and Mail
Why the electric grid now needs GridAI-style continuous control to function - Stock Titan
GridAI Technologies (NASDAQ: GRDX) Targets the Economics of Electricity as AI Turns Power Into a Strategic Cost - Digital Journal
Bond Watch: Will Entero Therapeutics Inc stock gain from lower inflationJuly 2025 WrapUp & Smart Money Movement Tracker - Bộ Nội Vụ
GridAI Technologies (GRDX) Targets the Economics of Electricity as AI Turns Power Into a Strategic Cost - NewMediaWire
RSI Check: Why retail investors favor Entero Therapeutics Inc stockJuly 2025 Fed Impact & Verified Short-Term Plans - Bộ Nội Vụ
GridAI's Role at the Center of Grid Intelligence Economics - The Globe and Mail
About Us - FinancialContent
Why GridAI says control, not hype, will shape grid AI economics ahead - Stock Titan
Market Trends: What are Entero Therapeutics Incs recent SEC filings showingJuly 2025 Institutional & Stepwise Trade Execution Plans - baoquankhu1.vn
GridAI Technologies (GRDX) and the Quiet Shift That Makes Electricity the Next AI Bottleneck - NewMediaWire
GridAI Technologies (NASDAQ: GRDX) and the Quiet Shift That Makes Electricity the Next AI Bottleneck - Digital Journal
GridAI and the Financial Mechanics of Grid Intelligence - ACCESS Newswire
GridAI: The Grid Is the New Battleground for AI Economics - The Globe and Mail
Entero Regains Nasdaq Compliance With Grid AI Acquisition - sctimes.com
GridAI Technologies Positioned at AI-Energy Convergence Point as Power Demands Surge - citybuzz -
Laser Focus WorldGridAI Technologies Corp. (NASDAQ: GRDX) Is ‘One to Watch’ - FinancialContent
Whittier Daily News: Local News, Sports, Things to DoGridAI Technologies Corp. (NASDAQ: GRDX) Is ‘One to Watch’ - FinancialContent
Entero Therapeutics Inc Stock (ENTO) Financials Data
There is no financial data for Entero Therapeutics Inc (ENTO). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.12%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):